Abstract
L-dopa, the major treatment for Parkinson's disease (PD), depletes S-adenosyl-L-methionine (SAM). Since SAM causes PD-like symptoms in rodents, the decreased efficacy of chronic L-dopa administered to PD patients may result from a rebound increase in SAM via methionine adenosyl transferase (MAT), which produces SAM from methionine and ATP. This was tested by administering intraperitoneally saline, or L-dopa to mice and assaying for brain MAT activity. As compared to controls, L-dopa (100 mg/kg) treatments of 1 and 2 times per day for 4 days did not significantly increase MAT activity. However, treatments of 1 and 2 times per day for 4 and 8 days did significantly increase the activity of MAT by 21.38% and 28.37%, respectively. These results show that short interval, chronic L-dopa treatments significantly increases MAT activity, which increases the production of SAM. SAM may physiologically antagonize the effects of L-dopa and biochemically decrease the concentrations of L-dopa and dopamine. Thus, an increase in MAT may be related to the decreased efficacy of chronic L-dopa therapy in PD.
Similar content being viewed by others
References
Barbeau, A. 1986. Extrapyramidal Disorders, Pages 87–152,in Vinken, P. J., Bruyn, G. W., and Klawans, H. L., (eds.) Handbook of Clinical Neurology, vol. 5(49), Elsevier.
Hefti, F., Melamed, E., and Wurtman, R. J. 1981. The site of dopamine formation in rat striatum after L-dopa administration. J. Pharmacol. Exp. Ther. 217:189–197.
Hornykiewicz, O. 1974. The Mechanisms of Action of L-dopa in Parkinson's Disease. Life Sci. 15:1249–1259.
Mena, M. A., Murandas, V., et al. 1986. Pharmacokinetics of L-dopa in patients with Parkinson's disease. Adv. in Neurol. 45:481–486.
Melamed, E., Globus, M., et al. 1983. Chronic L-dopa administration decreases striatal accumulation of dopamine from exogenous L-dopa in rats with intact nigrostriatal projections. Neurology 33:905–953.
Hunter, K. R., Shaw, K. M., Laurence, D. R., et al. 1973. Sustained levodopa therapy in parkinsonism. Lancet. 2:929–931.
Marsden, C. D., and Parkes, J. D. 1977. Success and problems of long-term levodopa therapy in Parkinson's disease. Lancet. 1:345–349.
Fahn, S., and Calne, D. B. 1978. Considerations in the management of parkinsonism. Neurology (NY) 28:5–7.
Barbeau, A. 1969. L-dopa therapy in Parkinson's disease: a critical review of nine years' experience. Can. Med. Assoc. J. 101:791–800.
McDowell, F. H., and Sweet, R. D. 1976. The on-off phenomenon. Pages 603–612.in Birkmayer, W., Hornykiewicz, O., (eds.) Advances in parkinsonism. Basel: Editiones Roche.
Barbeau, A. 1976. Pathophysiology of the oscillations in performance after long-term therapy with L-dopa. Pages 424–434,in Birkmayer, W., and Hornykiewicz, O., (eds.) Advances in parkinsonism. Basel: Editiones Roche.
Ludin, H. P., Bass-Verrey, F. 1976. Study of deterioration in long term treatment of parkinsonism with L-dopa plus decarboxylase inhibitor. J. Neural. Transm. 38:249–258.
Rinne, U. K. 1978. Recent advances in research of parkinsonism. Acta. Neurol. Scand. [Suppl 67] 157:77–113.
Lee, T., Seeman, P., Rajput, A., et al. 1978. Receptor basis for Dopaminergic supersensitivity in Parkinson's disease. Nature 273:59–61.
Reisine, T. D., Fields, J. Z., Yamamura, H. J., et al. 1977. Neurotransmitter receptor alterations in Parkinson's disease. Life Sci. 21:335–344.
Rinne, U. K. 1981. Treatment of Parkinson's disease: problems with a progressing disease. J. Neural. Transm. 51:161–174.
Creese, I., and Sibley, D. R. 1981. Receptor adaptations to centrally acting drugs. Annu. Rev. Pharmacol. Toxicol. 21:357–391.
Klawans, H. L., Goetz, C., Nausieda, P. A., et al. 1977. Levodopa-induced dopamine receptor supersensitivity. Ann. Neurol. 2:1259.
Sahakian, B. J., Carlson, K. R., DeGirolami, U., et al. 1980. Functional and structural consequences of long-term dietary L-dopa treatment in mice. Commun. Psychopharmacol. 4:169–176.
Suga, M. 1980. Effect of long-term L-dopa administration on the dopaminergic and cholinergic (muscarinic) receptors of striatum in 6-hydroxydopamine lesioned rats. Life Sci. 27:877–882.
Yahr, M. D. 1977. Long-term levodopa in Parkinson's disease. Lancet 1:706–707.
Lesser, R. P., Fahn, S., Snider, S. R., et al. 1979. Analysis of the clinical problems in parkinsonism and the complications of long term levodopa therapy. Neurology (NY) 29:1253–1260.
Weiner, W. J., Koller, W. C., Perlik, S., et al. 1980. Drug holiday and management of Parkinson's disease. Neurology (NY) 30:1257–1261.
Direnfeld, L. K., Feldman, R. G., Alexander, M. P., et al. 1980. Is L-dopa drug holiday useful? Neurology (NY) 30:785–788.
Charlton, C. G., and Way, E. L. 1978. Tremor induced by S-adenosyl methionine: possible relation to L-dopa effects. J. Pharm. Pharmac. 30:819–820.
Axelrod, J., and Tomchick, R. 1958. Enzymatic O-methylation of epinephrine and other catechols. J. Biol. Chem. 233:702–705.
Barbeau, A., et al. 1965. Pharmacology of 3,4-Dimethoxyphenylethylamine. Canad. Med. Ass. J. 92:347.
Wurtman, R. J., and Rose, C. M. 1970. L-dihydroxyphenyl-alanine: effect of S-adenosyl methionine in brain. Science 169:395–397.
Feuerstein, C. I., Tanche, M., Serre, F., et al. 1977. Does O-methyl-dopa play a role in levodopa-induced dyskinesia? Acta Neurol. Scandinav. 56:79–82.
Cantoni, G. L. 1952. The nature of the active methyl donor formed enzymatically from 1-methionine and adenosine triphosphate. J. Am. Chem. Soc. 74:2942–2948.
Mudd, H. S., Finkelstein, J. D., et al. 1965. Trans-sulfuration in mammals: microassays and tissue distributions of three enzymes of the pathway. J. Biol. Chem., vol. 240, 11:4382–4392.
Gharib, A., Sarda, B., et al. 1982. The regional concentration of S-adenosyl-L-methionine, S-adenosyl-L-homocysteine, and adenosine in rat brain. J. Neurochem. 38:810–815.
Cantoni, G. L., Mudd, S. H., and Andreoli, V. 1989. Affective disorders and S-adenosyl methionine: a new hypothesis. TINS 12; 9:319–324.
Charlton, C. 1990. A parallel relationship between Parkinson's disease and an excess of S-adenosyl-L-methionine-dependent biological methylation in the brain. Pages 333–339,in Nagatsu, T., et al. (eds.), Basic, Clinical and Therapeutic Aspects of Alzheimer's and Parkinson's Diseases, Vol 1, Plenum Press, New York.
Gancher, S. T., Nutt, J. G., and Woodward, W. 1988. Response to brief levodopa infusions in Parkinsonian patients with and without motor fluctuations. Neurology 38:712–716.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Benson, R., Crowell, B., Hill, B. et al. The effects of L-dopa on the activity of methionine adenosyltransferase: Relevance to L-dopa therapy and tolerance. Neurochem Res 18, 325–330 (1993). https://doi.org/10.1007/BF00969090
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00969090